The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality
Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read MoreTop Stories
The Nelson Memo: Igniting a Global Open Data
The landscape of scientific research is undergoing a seismic...
Rare Diseases – An Evolving Medical
A disease is considered rare when it affects fewer than 1 in...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability...
What’s Next for Global Capability Centers (GCCs)? Cactus Life Sciences at the NASSCOM GCC Summit 2025
The theme for this year’s NASSCOM GCC Summit, “The Next GCC Frontier: Ambition, Agility, Ascent,”...
Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements
HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...